Cargando…
Sexual dimorphism of the immune system predicts clinical outcomes in glioblastoma immunotherapy: A systematic review and meta-analysis
BACKGROUND: Biological differences based on sex have been documented throughout the scientific literature. Glioblastoma (GBM), the most common primary malignant brain tumor in adults, has a male sex incidence bias, however, no clinical trial data examining differential effects of treatment between s...
Autores principales: | Shireman, Jack M, Ammanuel, Simon, Eickhoff, Jens C, Dey, Mahua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268746/ https://www.ncbi.nlm.nih.gov/pubmed/35821678 http://dx.doi.org/10.1093/noajnl/vdac082 |
Ejemplares similares
-
A Comparison Between Chemo-Radiotherapy Combined With Immunotherapy and Chemo-Radiotherapy Alone for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis
por: Lara-Velazquez, Montserrat, et al.
Publicado: (2021) -
Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
por: Mitchell, Dana, et al.
Publicado: (2019) -
Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy
por: Capone, Imerio, et al.
Publicado: (2018) -
Spatial transcriptomics in glioblastoma: is knowing the right zip code the key to the next therapeutic breakthrough?
por: Shireman, Jack M., et al.
Publicado: (2023) -
Role of Microbiota in Sexually Dimorphic Immunity
por: Elderman, Marlies, et al.
Publicado: (2018)